Doctors at National Clinical Research are conducting a prescreening study for individuals experiencing memory issues. The study is designed to detect early signs of memory and thinking problems and includes a blood test to measure a protein called pTau, which may be associated with Alzheimer’s disease. Since this is a pre-screening study, no medication will be provided. The purpose is to identify individuals who may be eligible for an upcoming study evaluating a new investigational medication that may reduce the buildup of beta-amyloid plaques, one of the hallmark changes observed in the brains of people with Alzheimer’s.
Each visit is expected to last approximately 60 minutes. Study activities include a consultation with the doctor to review your medical and memory history, a brief memory assessment and a blood draw.
50 – 90
- Patient has experienced memory concerns within the last year
- Patient has a study partner (i.e. someone who is with you for at least 10 hours each week and would be willing to come with you for select appointments, if applicable)
- Patient has no medical conditions which may also cause memory loss (e.g. Parkinson’s, uncontrolled sleep apnea, Lewy-Body dementia)
- No stroke or seizure in the last 12 months
2 office visits
You may be reimbursed up to $125 for your participation.
Want to participate? Fill out the interest form! Click to Call Us!